Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Catheter Precision, Inc. Director's Dealing 2025

Dec 8, 2025

35479_dirs_2025-12-08_c336941f-af48-4956-89c7-0f8d77ba56de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2025-12-05

Reporting Person: JENKINS DAVID A (Chairman of the Board and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-05 Common Stock C 12064 Acquired 13799 Direct
2025-12-05 Common Stock C 30844 Acquired 34579 Indirect
2025-12-05 Common Stock C 98 Acquired 109 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-05 Series X Convertible Preferred Stock $0 C 2292.339 Disposed Common Stock (0) Direct
2025-12-05 Series X Convertible Preferred Stock $0 C 5860.54 Disposed Common Stock (0) Indirect
2025-12-05 Series X Convertible Preferred Stock $0 C 18.691 Disposed Common Stock (0) Indirect

Footnotes

F1: Shares held by a partnership of which the reporting person is the managing member of the managing partner

F2: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee

F3: Series X Convertible Preferred Stock has no expiration date